Eledon Pharmaceuticals, Inc. (ELDN) › Total AssetsEledon Pharmaceuticals, Inc. (ELDN) — Total AssetsAnnual figures by fiscal year, from SEC filings.2013: $32.29M2014: $107.74M2015: $67.97M2016: $1.20M2017: $20.89M2018: $17.03M2019: $10.93M2020: $197.19M2021: $170.55M2022: $92.79M2023: $89.07M2024: $177.41M2025: $169.01M$169.01M2013Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$169.01M-4.7%2024$177.41M+99.2%2023$89.07M-4.0%2022$92.79M-45.6%2021$170.55M-13.5%2020$197.19M+1703.9%2019$10.93M-35.8%2018$17.03M-18.5%2017$20.89M+1646.8%2016$1.20M-98.2%2015$67.97M-36.9%2014$107.74M+233.7%2013$32.29M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share